CXCL13 and esophageal squamous cell carcinoma: found that the post-treatment TME of non-responders with esophageal squamous cell carcinoma was enriched with CXCL13+CD8+Tex cells (exhausted phenotype) and TNFRSF4+CD4+ Tregs (immunosuppressive function) (50).